Evidence map›Paper›PMID 31064864›Full record

ReviewBiochemical Society transactions2019

MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms.

Valentina Gifford, Yoshifumi Itoh

Open access · bronzeAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 119 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Amoeboid-mesenchymal transition and the proteolytic control of cancer invasion plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Matrix Metalloproteinase 14 in Corneal Neovascularization.International journal of molecular sciences · 2026
    Review
  11. Article
  12. Article
  13. Identification of novelRSC medicinal chemistry · 2025
    Article
  14. Biological attributes of zinc-dependent endopeptidases in endothelial dysfunction associated with sepsis: a narrative review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. A role of CD20Frontiers in immunology · 2025
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Valentina GiffordThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, U.K.
Yoshifumi ItohThe Kennedy Institute of Rheumatology, University of Oxford, Oxford, U.K. yoshi.itoh@kennedy.ox.ac.uk.ORCID 0000-0002-2128-2823
University of Oxford · GB

Funding

Medical Research Council G0802007
6 · The paper itself

Abstract

Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a type I transmembrane proteinase that belongs to the matrix metalloproteinase (MMP) family. It is a potent modifier of cellular microenvironment and promotes cell migration and invasion of a wide variety of cell types both in physiological and pathological conditions. It promotes cell migration by degrading extracellular matrix on the cell surface and creates a migration path, by modifying cell adhesion property by shedding cell adhesion molecules to increase cell motility, and by altering cellular metabolism. Thus, MT1-MMP is a multifunctional cell motility enhancer. In this review, we will discuss the current understanding of the proteolytic and non-proteolytic mechanism of MT1-MMP-dependent cell migration.

Indexed as

Cell Adhesion MoleculesCell MovementEndocytosisHumansMatrix Metalloproteinase 14Membrane ProteinsProteolysisSubstrate SpecificityCell Adhesion MoleculesMatrix Metalloproteinase 14Membrane Proteinscell migrationcollagenECMinvasionMT1-MMP

Identifiers

PMID31064864
PMCPMC6599156
OpenAlexW2944434395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.